Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome

Ann Rheum Dis. 2011 Sep;70(9):1692-3. doi: 10.1136/ard.2010.144279. Epub 2011 Mar 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Etanercept
  • Female
  • Fever
  • Hereditary Autoinflammatory Diseases / drug therapy*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Middle Aged
  • Mutation
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Receptors, Tumor Necrosis Factor, Type I / genetics*
  • Treatment Failure
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF1A protein, human
  • Etanercept

Supplementary concepts

  • Periodic fever, familial, autosomal dominant